已核实 DOI PubMed 相关产品: 8

Controllable delivery of dual-drugs for combination therapy of chemotherapy and photodynamic therapy based on pH-responsive hyaluronic acid

Journal 2025 · IF 8.5 · 发表于 2025 年 2 月 18 日
作者: Yiqing Liu,Ying Zhang,Xinhao Dong,Jiawei Wang,Dan Li,Hua Zheng
阅读全文 在 PubMed 查看

摘要

The non-selectivity and undesirable water solubility are major limitations for the utilization of anti-cancer drugs in traditional therapy, leading to diminished therapeutic efficacy and severe side effects. Besides, the tumor inhibitory effect of photodynamic therapy (PDT) is limited, due to the limited depth of light penetration. However, combination therapies can reverse the dilemma that monotherapies face in clinical use. Here, a stimulus-sensitive drug delivery system was prepared by self-assembly for synchronized delivery and combination therapy. It was constructed by employing pH-responsive imine bonds to attach the chemotherapeutic drug daunorubicin (DNR) and the photosensitizer methyl aminolevulinate (MAL) to oxidized hyaluronic acid (OHA), named NPs(MAL/DNR). The nanoparticles demonstrated excellent inhibitory effect and synergistic effect in tumor suppression, as evidenced by in vitro cytotoxicity results (CI = 0.90, synergism). In summary, the prepared dual-drug nanoparticles can play a synergistic role in selectively killing tumor cells. This provides a new feasible direction for the use of combined chemotherapy and photodynamic therapy in the treatment of breast cancer.

本研究中使用的阿拉丁产品

8 款产品在本文中被引用